speb/financial-data huggingface dataset:
ASTRAZEN.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 400000.00
ASTRAZEN.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 400000.00
ASTRAZEN.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 3789600000.00
ASTRAZEN.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 0.00
ASTRAZEN.NS balance_sheet (annual, 2022-03-31) — Work In Process: 30600000.00
ASTRAZEN.NS income_statement (annual, 2022-03-31) — Write Off: 2900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — +Operating Expense: 4288200000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — +Total Revenue: 10029700000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 2278800000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1075200000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1106400000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -167600000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Amortization: 0.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 0.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 30952000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 25000000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Basic EPS: 39.70
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 4484200000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 621600000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -85200000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 72100000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 50000000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 5003400000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 5003400000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -200000000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 5003400000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -499900000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -64700000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 162400000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Change In Payable: 374400000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -236300000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -301900000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 519200000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Common Stock: 50000000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -200000000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 5886900000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 17100000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 4252600000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Current Assets: 8354700000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 35200000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 35200000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 3839300000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 46400000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Depreciation: 162600000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 162600000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 162600000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 162600000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 25000000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Diluted EPS: 39.70
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 992900000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 1400000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — EBIT: 1347300000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — EBITDA: 1509900000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — End Cash Position: 5003400000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -244800000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 1686000000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 497700000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -24900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 299300000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 0.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1242800000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 1808300000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Gross Profit: 5777100000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Interest Expense: 6300000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 6300000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Interest Income: 231200000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 231200000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -6300000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 231500000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Inventory: 1902100000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 5886900000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 181100000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 30952000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 15500000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 36900000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 36900000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 85642000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 1154100000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -1500000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Net Income: 992900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 992900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 992900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 992900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 992900000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1341000000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 992900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Net Interest Income: 224900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 224900000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -8000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Net PPE: 701900000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -50400000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 5886900000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 206700000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 85600000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 576600000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1887600000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Normalized Income: 1272555727.07
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 582900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Operating Income: 1488900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Operating Revenue: 10029700000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 25000000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 8000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 266175000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 332500000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 25700000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 15100000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -224900000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 30927000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 2100000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 573100000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Other Payable: 302300000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Other Properties: 688638000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 105900000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 107171000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Other Special Charges: -24900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Payables: 2606700000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 416800000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 266700000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Pretax Income: 1341000000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 16700000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -85200000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 184300000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 4252600000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 162600000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 0.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 0.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 1400000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 402300000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 4556400000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 34800000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 662200000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 961500000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Share Issued: 25000000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Special Income Charges: -377700000.00
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 23700000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 5886900000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 5886900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -98044272.93
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Tax Provision: 348100000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.26
ASTRAZEN.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -408200000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Total Assets: 9848700000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 5886900000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Total Debt: 72100000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 5886900000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Total Expenses: 8540800000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 3961800000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 1494000000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 122500000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 24200000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -377700000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -377700000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Work In Process: 16700000.00
ASTRAZEN.NS balance_sheet (annual, 2023-03-31) — Working Capital: 4515400000.00
ASTRAZEN.NS income_statement (annual, 2023-03-31) — Write Off: 300000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — +Operating Expense: 4508400000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — +Total Revenue: 12955300000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1965100000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1531300000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1207000000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -222000000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Amortization: 1300000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 1300000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 24676000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 25000000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Basic EPS: 64.60
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 5003400000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 621500000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -107600000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 45900000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 50000000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 5055700000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 5055700000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -400000000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 5055700000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -376700000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -74400000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -19500000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Change In Payable: -313700000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -506200000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -1281700000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 52300000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Common Stock: 50000000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -400000000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 7119200000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 6500000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 6732600000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Current Assets: 9327100000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 18100000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 18100000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 3571200000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 219700000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Depreciation: 148100000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 149400000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 149400000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 148100000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 25000000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Diluted EPS: 64.60
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 1615100000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 2700000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — EBIT: 2207400000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — EBITDA: 2356800000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — End Cash Position: 5055700000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -443800000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 1993100000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 171100000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -300000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 421500000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 21100000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 1753300000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 1855400000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Gross Profit: 6222700000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Interest Expense: 12000000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 12000000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Interest Income: 325700000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 325700000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -5200000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 320900000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Inventory: 2278800000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 7119200000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: 217400000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 0.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 19500000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 27800000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 27800000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 62096000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 1207900000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 1500000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Net Income: 1615100000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 1615100000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 1615100000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 1615100000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 1615100000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 2195400000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 1615100000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Net Interest Income: 313700000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 313700000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Net PPE: 648400000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -103500000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 7098100000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 0.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 212500000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 62100000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 568500000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 2204600000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Normalized Income: 1503130327.05
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 278700000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Operating Income: 1714300000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Operating Revenue: 12955300000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 25000000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 278530000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 214900000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 32900000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 21100000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 13400000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -313700000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 17494000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 20200000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 603000000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Other Payable: 307400000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Other Properties: 645714000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 161700000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 181508000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Other Special Charges: -164600000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Payables: 2341800000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 280600000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 296900000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Pretax Income: 2195400000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 52600000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -107600000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 225000000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 6732600000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 149400000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 4600000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 4600000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 2700000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 5781500000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 4100000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 915400000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1336900000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Share Issued: 25000000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Special Income Charges: 152200000.00
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 27400000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 7119200000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 7098100000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 40230327.05
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Tax Provision: 580300000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.26
ASTRAZEN.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -564300000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Total Assets: 10780300000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 7119200000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Total Debt: 45900000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 7119200000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Total Expenses: 11241000000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 3661100000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 1453200000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 89900000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 66600000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 152200000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 152200000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Work In Process: 47300000.00
ASTRAZEN.NS balance_sheet (annual, 2024-03-31) — Working Capital: 5755900000.00
ASTRAZEN.NS income_statement (annual, 2024-03-31) — Write Off: 12400000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 3169200000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 1497600000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 51000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 171200000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 50000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 4965200000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 5079700000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 50000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 6793500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 2400000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 10665300000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 37900000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 37900000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 4748300000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 444700000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 19000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 674900000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 3819900000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 6793500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 51000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 133300000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 133300000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 632900000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 674900000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 6774500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 377800000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 25000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 264800000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 680000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 6743500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 17500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 105000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 672500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 3300000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 114500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Payables: 3194800000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 25000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 6793500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 6774500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 12413000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 6793500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 171200000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 6793500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 5619500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 1747700000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 871200000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 25600000.00
ASTRAZEN.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 5917000000.00
ASTRAZEN.NS income_statement (quarterly, 2024-12-31) — Other Special Charges: 4000000.00
ASTRAZEN.NS income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 331500000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — +Operating Expense: 4979000000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1521900000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — +Total Revenue: 17132900000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 4804800000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 4563000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4563000000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1848800000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1848800000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1517900000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1517900000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -228600000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -228600000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Amortization: 14500000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 14500000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 0.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 0.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 36500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 36500000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 25000000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 25000000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Basic EPS: 46.30
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 23.30
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 5055700000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 979100000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 979100000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -17500000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 357300000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 357300000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 50000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 50000000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 5361400000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5361400000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5361400000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5361400000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -600000000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 5361400000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 5361400000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -3206200000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -335100000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 224500000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Change In Payable: 2598100000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -316900000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -1032200000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 305700000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Common Stock: 50000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 50000000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -600000000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 7703500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 7703500000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 0.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 0.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 10005800000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2596100000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Current Assets: 13423500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 13423500000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 62800000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 62800000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 62800000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 62800000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 7030000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 7030000000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 1129400000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 1129400000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Depreciation: 385400000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 399900000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 399900000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 176900000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 385400000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 176900000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 25000000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 25000000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Diluted EPS: 46.30
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 23.30
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1157400000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 582500000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 5600000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 5600000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — EBIT: 1578200000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — EBIT: 791500000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — EBITDA: 1978100000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — EBITDA: 968400000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — End Cash Position: 5361400000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -655900000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 5302100000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 5302100000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 636100000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -3200000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 509400000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 6600000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 6600000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 2077400000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2077400000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 2153800000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2153800000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Gross Profit: 7127100000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 2208700000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Interest Expense: 14600000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 6800000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 14600000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 6800000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Interest Income: 315600000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 315600000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -14600000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 318400000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Inventory: 5485000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 5485000000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 7703500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 7703500000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: 308000000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 36500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 36500000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 19500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 19500000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 294500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 294500000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 294500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 294500000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 63200000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 63200000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 1155200000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1155200000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -7400000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Net Income: 1157400000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Net Income: 582500000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1157400000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 582500000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1157400000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 582500000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1157400000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 582500000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1157400000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 582500000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 1563600000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1157400000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 582500000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Net Interest Income: 301000000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -6800000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 301000000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -6800000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Net PPE: 635900000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 635900000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -10400000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 7696900000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 7696900000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 90000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 90000000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 415600000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 415600000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 63200000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 63200000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 662100000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 662100000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 2861300000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1025200000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Normalized Income: 1811157789.72
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 624663884.29
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 653600000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Operating Income: 2148100000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Operating Income: 686800000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Operating Revenue: 17132900000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 4804800000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 25000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 25000000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 561700000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 561700000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 183100000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 183100000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 71500000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 71500000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 6600000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 6600000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 9900000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 9900000.00
ASTRAZEN.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -301000000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: -100000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: -100000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 90000000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 90000000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 1400000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 161500000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 571000000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 464100000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Other Payable: 247100000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 247100000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Other Properties: 635800000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 635800000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 146600000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 146600000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 163600000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 163600000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Other Special Charges: -89300000.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Other Special Charges: 56800000.00
ASTRAZEN.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ASTRAZEN.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Payables: 4922100000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Payables: 4922100000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 850900000.00
ASTRAZEN.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 850900000.00
ASTRAZEN.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 576100000.00